Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Transcutaneous CO2 monitoring: a new tool to identify spontaneous breathing trial failure during weaning from mechanical ventilation. A pilot cohort study.

Henao-Brasseur J, Bedel J, Mutlu G, Grimaldi D, Brasseur F, Laurent V, Troché G, Legriel S, Bedos JP, Planquette B.

Intensive Care Med. 2016 Jun;42(6):1078-9. doi: 10.1007/s00134-016-4247-1. Epub 2016 Feb 10. No abstract available.

PMID:
26862068
2.

Local immunostimulation leading to rejection of accepted male skin grafts by female mice as a model for cancer immunotherapy.

Bourdeaux C, Lurquin C, Jacquemart I, Lethé B, Brasseur F, van Baren N, Baurain JF, Dyson J, Van Snick J, Uyttenhove C, Boon T.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3502-7. doi: 10.1073/pnas.1401115111. Epub 2014 Feb 18.

3.

[Prognostic factors of pregnancy in intra-uterine insemination with sperm of donor: a review of 535 cycles over 7 years].

Boulard V, Charbit B, Brasseur F, Lourdel E, Copin H, Merviel P.

J Gynecol Obstet Biol Reprod (Paris). 2013 Feb;42(1):40-8. doi: 10.1016/j.jgyn.2012.10.010. Epub 2012 Nov 22. French.

4.

Minimal tolerance to a tumor antigen encoded by a cancer-germline gene.

Huijbers IJ, Soudja SM, Uyttenhove C, Buferne M, Inderberg-Suso EM, Colau D, Pilotte L, Powis de Tenbossche CG, Chomez P, Brasseur F, Schmitt-Verhulst AM, Van den Eynde BJ.

J Immunol. 2012 Jan 1;188(1):111-21. doi: 10.4049/jimmunol.1002612. Epub 2011 Dec 2.

5.

[Pregnancy predictive factors in case of double embryo transfer during "Top Quality" attempts].

Cabry-Goubet R, Lourdel E, Brzakowski M, Urrutiaguer-Grenier N, Brasseur F, Demailly P, Devaux A, Copin H, Merviel P.

Gynecol Obstet Fertil. 2013 Mar;41(3):168-72. doi: 10.1016/j.gyobfe.2011.07.032. Epub 2011 Oct 22. French.

PMID:
22019742
6.

Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.

Seremet T, Brasseur F, Coulie PG.

Cancer J. 2011 Sep-Oct;17(5):325-30. doi: 10.1097/PPO.0b013e3182326004. Review.

PMID:
21952282
7.

[Wrong side iliofascial block in a patient with hip fracture].

Petrova E, Brasseur F, Benhamou D.

Ann Fr Anesth Reanim. 2010 Nov;29(11):796-8. doi: 10.1016/j.annfar.2010.08.014. Epub 2010 Oct 29. French. Erratum in: Ann Fr Anesth Reanim. 2011 Jan;30(1):94.

PMID:
21035998
8.

[Professional Practice Evaluation: How to improve quality management in procreation centers?].

Cabry-Goubet R, Lourdel E, Brasseur F, Sanguinet P, Demailly P, Devaux A, Copin H, Merviel P.

Gynecol Obstet Fertil. 2010 Oct;38(10):581-7. doi: 10.1016/j.gyobfe.2010.08.011. Epub 2010 Sep 29. French.

PMID:
20884269
9.

Frequent MAGE mutations in human melanoma.

Caballero OL, Zhao Q, Rimoldi D, Stevenson BJ, Svobodová S, Devalle S, Röhrig UF, Pagotto A, Michielin O, Speiser D, Wolchok JD, Liu C, Pejovic T, Odunsi K, Brasseur F, Van den Eynde BJ, Old LJ, Lu X, Cebon J, Strausberg RL, Simpson AJ.

PLoS One. 2010 Sep 16;5(9). pii: e12773. doi: 10.1371/journal.pone.0012773. Erratum in: PLoS One. 2010;5(11). doi: 10.1371/annotation/3ee2788f-0c44-429f-85c3-d626c9fedc21.

10.

[Intrauterine inseminations in women over 35: the pros].

Merviel P, Lourdel E, Cabry R, Brzakowski M, Dupond S, Boulard V, Demailly P, Brasseur F, Copin H, Devaux A.

Gynecol Obstet Fertil. 2010 Apr;38(4):283-9. doi: 10.1016/j.gyobfe.2010.02.014. Epub 2010 Apr 1. French. No abstract available.

PMID:
20362484
11.

Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens.

Kholmanskikh O, van Baren N, Brasseur F, Ottaviani S, Vanacker J, Arts N, van der Bruggen P, Coulie P, De Plaen E.

Int J Cancer. 2010 Oct 1;127(7):1625-36. doi: 10.1002/ijc.25182.

12.

Physiopathology of human embryonic implantation: clinical incidences.

Merviel P, Lourdel E, Cabry R, Boulard V, Brzakowski M, Demailly P, Brasseur F, Copin H, Devaux A.

Folia Histochem Cytobiol. 2009;47(5):S25-34. doi: 10.2478/v10042-009-0058-3.

PMID:
20067890
13.

[The bioethics law revision: comparative analysis of contributions from different public and professional offices. Assisted Reproductive Technology, embryo and stem cells research, umbilical cord blood bank].

Merviel P, Cabry R, Lourdel E, Brasseur F, Devaux A, Copin H.

Gynecol Obstet Fertil. 2009 Sep;37(9):733-41. doi: 10.1016/j.gyobfe.2009.05.010. Epub 2009 Aug 8. Review. French.

PMID:
19665913
14.

[Premature ovarian failure: which protocols?].

Merviel P, Lourdel E, Boulard V, Cabry R, Claeys C, Oliéric MF, Sanguinet P, Brasseur F, Henri I, Copin H.

Gynecol Obstet Fertil. 2008 Sep;36(9):872-81. doi: 10.1016/j.gyobfe.2008.06.015. Epub 2008 Aug 13. Review. French.

PMID:
18703373
15.

Selective cancer-germline gene expression in pediatric brain tumors.

Jacobs JF, Grauer OM, Brasseur F, Hoogerbrugge PM, Wesseling P, Gidding CE, van de Rakt MW, Figdor CG, Coulie PG, de Vries IJ, Adema GJ.

J Neurooncol. 2008 Jul;88(3):273-80. doi: 10.1007/s11060-008-9577-6. Epub 2008 Apr 9.

16.

Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells.

Carrasco J, Van Pel A, Neyns B, Lethé B, Brasseur F, Renkvist N, van der Bruggen P, van Baren N, Paulus R, Thielemans K, Boon T, Godelaine D.

J Immunol. 2008 Mar 1;180(5):3585-93.

17.
18.

Expression of BORIS in melanoma: lack of association with MAGE-A1 activation.

Kholmanskikh O, Loriot A, Brasseur F, De Plaen E, De Smet C.

Int J Cancer. 2008 Feb 15;122(4):777-84.

19.

[Management of an ovarian stimulation in case of a Kallmann-De Morsier syndrome. The role of LH].

Heraud MH, Grenier N, Cabry R, Lourdel E, Sanguinet P, Brasseur F, Henry I, Copin H, Merviel P.

Gynecol Obstet Fertil. 2007 Jun;35(6):548-55. Epub 2007 May 23. French.

PMID:
17512237
20.

[Against the obligation of single embryo transfer].

Merviel P, Lourdel E, Cabry R, Grenier N, Sanguinet P, Henry I, Brasseur F, Copin H.

Gynecol Obstet Fertil. 2007 May;35(5):474-9. Epub 2007 Mar 29. French. No abstract available.

PMID:
17398139
21.

Patterns of somatic mutation in human cancer genomes.

Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR.

Nature. 2007 Mar 8;446(7132):153-8.

22.

A new tumor-specific antigen encoded by MAGE-C2 and presented to cytolytic T lymphocytes by HLA-B44.

Godelaine D, Carrasco J, Brasseur F, Neyns B, Thielemans K, Boon T, Van Pel A.

Cancer Immunol Immunother. 2007 Jun;56(6):753-9. Epub 2006 Nov 10.

PMID:
17096150
23.

Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR.

Jacobs JF, Brasseur F, Hulsbergen-van de Kaa CA, van de Rakt MW, Figdor CG, Adema GJ, Hoogerbrugge PM, Coulie PG, de Vries IJ.

Int J Cancer. 2007 Jan 1;120(1):67-74.

24.

Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules.

So T, Hanagiri T, Chapiro J, Colau D, Brasseur F, Yasumoto K, Boon T, Coulie PG.

Cancer Immunol Immunother. 2007 Feb;56(2):259-69. Epub 2006 Jun 7.

PMID:
16758204
25.

Unambiguous identification of the expressed MAGE-A genes on a DNA microarray.

Zammatteo N, Davril C, Brasseur F, Hamels S, De Plaen E, Boon T, Remacle J.

Clin Chem. 2005 Dec;51(12):2420-1. No abstract available.

26.

Somatic mutations of the protein kinase gene family in human lung cancer.

Davies H, Hunter C, Smith R, Stephens P, Greenman C, Bignell G, Teague J, Butler A, Edkins S, Stevens C, Parker A, O'Meara S, Avis T, Barthorpe S, Brackenbury L, Buck G, Clements J, Cole J, Dicks E, Edwards K, Forbes S, Gorton M, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jones D, Kosmidou V, Laman R, Lugg R, Menzies A, Perry J, Petty R, Raine K, Shepherd R, Small A, Solomon H, Stephens Y, Tofts C, Varian J, Webb A, West S, Widaa S, Yates A, Brasseur F, Cooper CS, Flanagan AM, Green A, Knowles M, Leung SY, Looijenga LH, Malkowicz B, Pierotti MA, Teh BT, Yuen ST, Lakhani SR, Easton DF, Weber BL, Goldstraw P, Nicholson AG, Wooster R, Stratton MR, Futreal PA.

Cancer Res. 2005 Sep 1;65(17):7591-5.

27.

Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma.

Kruit WH, van Ojik HH, Brichard VG, Escudier B, Dorval T, Dréno B, Patel P, van Baren N, Avril MF, Piperno S, Khammari A, Stas M, Ritter G, Lethé B, Godelaine D, Brasseur F, Zhang Y, van der Bruggen P, Boon T, Eggermont AM, Marchand M.

Int J Cancer. 2005 Nov 20;117(4):596-604.

28.

A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer.

Stephens P, Edkins S, Davies H, Greenman C, Cox C, Hunter C, Bignell G, Teague J, Smith R, Stevens C, O'Meara S, Parker A, Tarpey P, Avis T, Barthorpe A, Brackenbury L, Buck G, Butler A, Clements J, Cole J, Dicks E, Edwards K, Forbes S, Gorton M, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jones D, Kosmidou V, Laman R, Lugg R, Menzies A, Perry J, Petty R, Raine K, Shepherd R, Small A, Solomon H, Stephens Y, Tofts C, Varian J, Webb A, West S, Widaa S, Yates A, Brasseur F, Cooper CS, Flanagan AM, Green A, Knowles M, Leung SY, Looijenga LH, Malkowicz B, Pierotti MA, Teh B, Yuen ST, Nicholson AG, Lakhani S, Easton DF, Weber BL, Stratton MR, Futreal PA, Wooster R.

Nat Genet. 2005 Jun;37(6):590-2. Epub 2005 May 22.

PMID:
15908952
29.

Use of GNRH antagonists in reproductive medicine.

Merviel P, Najas S, Campy H, Floret S, Brasseur F.

Minerva Ginecol. 2005 Feb;57(1):29-43. Review.

PMID:
15758864
30.

Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines.

Michiels A, Tuyaerts S, Bonehill A, Corthals J, Breckpot K, Heirman C, Van Meirvenne S, Dullaers M, Allard S, Brasseur F, van der Bruggen P, Thielemans K.

Gene Ther. 2005 May;12(9):772-82.

PMID:
15750615
31.

High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens.

Germeau C, Ma W, Schiavetti F, Lurquin C, Henry E, Vigneron N, Brasseur F, Lethé B, De Plaen E, Velu T, Boon T, Coulie PG.

J Exp Med. 2005 Jan 17;201(2):241-8.

32.

Lung cancer: intragenic ERBB2 kinase mutations in tumours.

Stephens P, Hunter C, Bignell G, Edkins S, Davies H, Teague J, Stevens C, O'Meara S, Smith R, Parker A, Barthorpe A, Blow M, Brackenbury L, Butler A, Clarke O, Cole J, Dicks E, Dike A, Drozd A, Edwards K, Forbes S, Foster R, Gray K, Greenman C, Halliday K, Hills K, Kosmidou V, Lugg R, Menzies A, Perry J, Petty R, Raine K, Ratford L, Shepherd R, Small A, Stephens Y, Tofts C, Varian J, West S, Widaa S, Yates A, Brasseur F, Cooper CS, Flanagan AM, Knowles M, Leung SY, Louis DN, Looijenga LH, Malkowicz B, Pierotti MA, Teh B, Chenevix-Trench G, Weber BL, Yuen ST, Harris G, Goldstraw P, Nicholson AG, Futreal PA, Wooster R, Stratton MR.

Nature. 2004 Sep 30;431(7008):525-6.

PMID:
15457249
33.

Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules.

Bonehill A, Heirman C, Tuyaerts S, Michiels A, Breckpot K, Brasseur F, Zhang Y, Van Der Bruggen P, Thielemans K.

J Immunol. 2004 Jun 1;172(11):6649-57.

34.

Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignancies.

Wilke M, Dolstra H, Maas F, Pool J, Brouwer R, Falkenburg JH, Rebello A, Lamers F, Schuuring E, Kluin P, Brasseur F, Goulmy E.

Hematol J. 2003;4(5):315-20.

PMID:
14502255
35.

Tumor-specific shared antigenic peptides recognized by human T cells.

Van Der Bruggen P, Zhang Y, Chaux P, Stroobant V, Panichelli C, Schultz ES, Chapiro J, Van Den Eynde BJ, Brasseur F, Boon T.

Immunol Rev. 2002 Oct;188:51-64. Review.

PMID:
12445281
36.

New chips for molecular biology and diagnostics.

Zammatteo N, Hamels S, De Longueville F, Alexandre I, Gala JL, Brasseur F, Remacle J.

Biotechnol Annu Rev. 2002;8:85-101. Review.

PMID:
12436916
37.

DNA microarray to monitor the expression of MAGE-A genes.

Zammatteo N, Lockman L, Brasseur F, De Plaen E, Lurquin C, Lobert PE, Hamels S, Boon T, Remacle J.

Clin Chem. 2002 Jan;48(1):25-34.

38.

MAGE-A genes are not expressed in human leukemias.

Chambost H, van Baren N, Brasseur F, Olive D.

Leukemia. 2001 Nov;15(11):1769-71.

PMID:
11681419
39.

An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes.

Probst-Kepper M, Stroobant V, Kridel R, Gaugler B, Landry C, Brasseur F, Cosyns JP, Weynand B, Boon T, Van Den Eynde BJ.

J Exp Med. 2001 May 21;193(10):1189-98.

40.

Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value?

Gala JL, Loric S, Guiot Y, Denmeade SR, Gady A, Brasseur F, Heusterspreute M, Eschwège P, De Nayer P, Van Cangh P, Tombal B.

Clin Cancer Res. 2000 Oct;6(10):4049-54.

41.

Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4.

Landry C, Brasseur F, Spagnoli GC, Marbaix E, Boon T, Coulie P, Godelaine D.

Int J Cancer. 2000 Jun 15;86(6):835-41.

42.

Expression of gene MAGE-A4 in Reed-Sternberg cells.

Chambost H, Van Baren N, Brasseur F, Godelaine D, Xerri L, Landi SJ, Theate I, Plumas J, Spagnoli GC, Michel G, Coulie PG, Olive D.

Blood. 2000 Jun 1;95(11):3530-3.

43.

Cytolytic T lymphocytes raised against a human bladder carcinoma recognize an antigen encoded by gene MAGE-A12.

Heidecker L, Brasseur F, Probst-Kepper M, Guéguen M, Boon T, Van den Eynde BJ.

J Immunol. 2000 Jun 1;164(11):6041-5.

44.

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.

Morel S, Lévy F, Burlet-Schiltz O, Brasseur F, Probst-Kepper M, Peitrequin AL, Monsarrat B, Van Velthoven R, Cerottini JC, Boon T, Gairin JE, Van den Eynde BJ.

Immunity. 2000 Jan;12(1):107-17.

45.

Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries.

Serrano A, Lethé B, Delroisse JM, Lurquin C, De Plaen E, Brasseur F, Rimoldi D, Boon T.

Int J Cancer. 1999 Nov 26;83(5):664-9.

46.
47.

cDNA and protein characterization of human MAGE-10.

Rimoldi D, Salvi S, Reed D, Coulie P, Jongeneel VC, De Plaen E, Brasseur F, Rodriguez AM, Boon T, Cerottini JC.

Int J Cancer. 1999 Sep 9;82(6):901-7.

48.

Genes encoding tumor-specific antigens are expressed in human myeloma cells.

van Baren N, Brasseur F, Godelaine D, Hames G, Ferrant A, Lehmann F, André M, Ravoet C, Doyen C, Spagnoli GC, Bakkus M, Thielemans K, Boon T.

Blood. 1999 Aug 15;94(4):1156-64.

49.

Characterization of the GAGE genes that are expressed in various human cancers and in normal testis.

De Backer O, Arden KC, Boretti M, Vantomme V, De Smet C, Czekay S, Viars CS, De Plaen E, Brasseur F, Chomez P, Van den Eynde B, Boon T, van der Bruggen P.

Cancer Res. 1999 Jul 1;59(13):3157-65.

50.

Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma.

Huang LQ, Brasseur F, Serrano A, De Plaen E, van der Bruggen P, Boon T, Van Pel A.

J Immunol. 1999 Jun 1;162(11):6849-54.

Supplemental Content

Loading ...
Support Center